Veracyte | VCYT - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Agenus USD 231.82M 17.42M 2026-06
Agilent USD 2.27B 35M 2026-03
Anika Therapeutics USD 22.15M 1.18M 2026-06
Arrowhead Research USD 283.35M 11.87M 2026-06
Bruker USD 1.2B 150.4M 2026-06
Heron Therapeutics USD 92.14M 1.63M 2026-06
Illumina USD 1.58B 12M 2026-06
Intrexon USD 23.02M 38K 2024-06
Karyopharm Therapeutics USD 117.3M 25.24M 2026-03
Laboratory Of America USD 2.12B 516.4M 2026-06
Ligand Pharmaceuticals USD 46.74M 6.07M 2026-06
Myriad Genetics USD 130.7M 500K 2026-06
Rigel Pharmaceuticals USD 94.4M 7.76M 2025-09
Roche Holding CHF 28.85B 846M 2026-06
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Siemens EUR 45.11B 4.4B 2026-06
Sonic Healthcare AUD 2.23B 92.84M 2024-12
Thermo Fisher Scientific USD 15.07B 448M 2026-06
Veracyte USD 62.74M 6.62M 2026-06
Waters USD 2.27B 1.03B 2026-03